• Explore /
  • Poster
  • / Two-fraction stereotactic MRI-guided ablative radiotherapy with simultaneous boost to dominant intraprostatic lesion: Results from the 2SMART phase 2 trial.

Two-fraction stereotactic MRI-guided ablative radiotherapy with simultaneous boost to dominant intraprostatic lesion: Results from the 2SMART phase 2 trial.

Abstract Poster

Authors

null

Wee Loon Ong

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Wee Loon Ong , Patrick Cheung , Hans T. Chung , William Chu , Jay Detsky , Stanley K. Liu , Gerard Morton , Ewa Szumacher , Chia-Lin Tseng , Danny Vesprini , Melanie Davidson , Ananth Ravi , Merrylee McGuffin , Liying Zhang , Alexandre Mamedov , Andrea Deabreu , Meghan Poon , Andrew Loblaw

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03588819

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 349)

DOI

10.1200/JCO.2023.41.6_suppl.349

Abstract #

349

Poster Bd #

M7

Abstract Disclosures

Similar Posters

First Author: Ryan Phillips

First Author: John Nikitas

First Author: Bridget F. Koontz

First Author: Amar Upadhyaya Kishan